80 related articles for article (PubMed ID: 1578143)
1. Enhanced expression of the complement-regulatory factor C8 binding protein (C8bp) on U937 cells after stimulation with IL-1 beta, endotoxin, IFN-gamma, or phorbol ester.
Schieren G; Janssen O; Hänsch GM
J Immunol; 1992 May; 148(10):3183-8. PubMed ID: 1578143
[TBL] [Abstract][Full Text] [Related]
2. Paroxysmal nocturnal hemoglobinuria. Enhanced stimulation of platelets by the terminal complement components is related to the lack of C8bp in the membrane.
Blaas P; Berger B; Weber S; Peter HH; Hänsch GM
J Immunol; 1988 May; 140(9):3045-51. PubMed ID: 3361126
[TBL] [Abstract][Full Text] [Related]
3. Expression of the complement regulator factor C8 binding protein on human glomerular cells protects them from complement-mediated killing.
Schieren G; Schönermark M; Braunger M; Hänsch GM
Exp Nephrol; 1994; 2(5):299-305. PubMed ID: 7812736
[TBL] [Abstract][Full Text] [Related]
4. The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.
Schönermark S; Filsinger S; Berger B; Hänsch GM
Immunology; 1988 Apr; 63(4):585-90. PubMed ID: 3366469
[TBL] [Abstract][Full Text] [Related]
5. Paroxysmal nocturnal hemoglobinuria type III. Lack of an erythrocyte membrane protein restricting the lysis by C5b-9.
Hänsch GM; Schönermark S; Roelcke D
J Clin Invest; 1987 Jul; 80(1):7-12. PubMed ID: 3597779
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of homologous complement by CD59 is mediated by a species-selective recognition conferred through binding to C8 within C5b-8 or C9 within C5b-9.
Rollins SA; Zhao J; Ninomiya H; Sims PJ
J Immunol; 1991 Apr; 146(7):2345-51. PubMed ID: 1706395
[TBL] [Abstract][Full Text] [Related]
7. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
8. Enhanced reactive lysis of paroxysmal nocturnal hemoglobinuria erythrocytes by C5b-9 does not involve increased C7 binding or cell-bound C3b.
Rosenfeld SI; Jenkins DE; Leddy JP
J Immunol; 1985 Jan; 134(1):506-11. PubMed ID: 3964820
[TBL] [Abstract][Full Text] [Related]
9. Anti-idiotypic antibodies derived against C8, C9 and perforin bind homologous restriction factor.
Young JD; Jiang S; Liu CC; Hasselkus-Light CS
J Immunol Methods; 1990 Mar; 128(1):133-42. PubMed ID: 1691232
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the membrane attack complex of complement. Evidence that C8 gamma is not the target of homologous restriction factors.
Davé SJ; Sodetz JM
J Immunol; 1990 Apr; 144(8):3087-90. PubMed ID: 2324496
[TBL] [Abstract][Full Text] [Related]
11. Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
Morgan BP; Imagawa DK; Dankert JR; Ramm LE
J Immunol; 1986 May; 136(9):3402-6. PubMed ID: 3514758
[TBL] [Abstract][Full Text] [Related]
12. Incorporation of human complement C8 into the membrane attack complex is mediated by a binding site located within the C8beta MACPF domain.
Brannen CL; Sodetz JM
Mol Immunol; 2007 Feb; 44(5):960-5. PubMed ID: 16624411
[TBL] [Abstract][Full Text] [Related]
13. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
[TBL] [Abstract][Full Text] [Related]
14. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
Tomlinson S; Whitlow MB; Nussenzweig V
J Immunol; 1994 Feb; 152(4):1927-34. PubMed ID: 7509832
[TBL] [Abstract][Full Text] [Related]
15. Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.
Schönermark S; Rauterberg EW; Shin ML; Löke S; Roelcke D; Hänsch GM
J Immunol; 1986 Mar; 136(5):1772-6. PubMed ID: 2419413
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CD59 expression on the human endothelial cell line EA.hy 926.
Meri S; Mattila P; Renkonen R
Eur J Immunol; 1993 Oct; 23(10):2511-6. PubMed ID: 7691609
[TBL] [Abstract][Full Text] [Related]
17. Isolation of homologous restriction factor from human urine. Immunochemical properties and biologic activity.
Zalman LS; Brothers MA; Müller-Eberhard HJ
J Immunol; 1989 Sep; 143(6):1943-7. PubMed ID: 2476489
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal mesothelial cells produce complement factors and express CD59 that inhibits C5b-9-mediated cell lysis.
Barbano G; Cappa F; Prigione I; Tedesco F; Pausa M; Gugliemino R; Pistoia V; Gusmano R; Perfumo F
Adv Perit Dial; 1999; 15():253-7. PubMed ID: 10682113
[TBL] [Abstract][Full Text] [Related]
19. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation.
Capey S; van den Berg CW
Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide and interleukin 1 inhibit interferon-gamma-induced Fc receptor expression on human monocytes.
Arend WP; Ammons JT; Kotzin BL
J Immunol; 1987 Sep; 139(6):1873-9. PubMed ID: 2957441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
